Calls for Papers

Writing at a laptop

The Journal of Clinical and Translational Science - the Official Journal of ACTS and CR Forum - highlights outstanding work in the following areas:

  • Basic and Preclinical Research
  • Clinical Research
  • Education
  • Research Methods and Technology
  • Implementation, Policy, and Community Engagement
  • Translational Research Design and Analysis

Manuscripts may be submitted for peer review in any of the Journal’s article types listed below:

  • Research Articles
  • Expedited Reports
  • Brief Reports
  • Letters
  • Special Communications
  • Comments
  • Review Articles
  • Editorials
  • Perspectives
  • Conference Proceedings
  • Translational Science Case Studies

For a full description of each manuscript category, as well as information on the submission of manuscripts, journal policy and journal style, please visit the JCTS Instructions for Contributors on Cambridge Core.

JCTS is accepting manuscripts for upcoming thematic issues! Learn more about each thematic issue and the submission deadlines below:

Advancing Translational Science through Real-World Data and Real-World Evidence

Deadline for Submission: January 31, 2023

Innovations for Enhancing the Informativeness and Quality of Clinical Trials

Deadline for Submission: January 31, 2023

Decentralized research: realizing the promise of virtual clinical trials

Deadline for Submission: March 30, 2023

Well-Being in Clinical and Translational Science

Deadline for Submission: April 1, 2023

Integration of Social Determinants of Health with Clinical and Translational Science

Deadline for Submission: July 31, 2023

Other calls for papers on translational research topics:

Leveraging the power of communities in public health crises: A sustainable model for health equity. American Journal of Public Health.

Deadline for Submission: February 1, 2023

The AJPH, in collaboration with the NIH, is seeking submissions for a supplemental issue on the science of community-engaged research in documenting and intervening to reduce or eliminate COVID-19-related health disparities and advance health equity. Original articles must focus on one or more populations that were disproportionately affected by the COVID-19 pandemic.

Community Science. Scientific Reports.

Deadline for Submission: March 28, 2023

Welcomes submissions of primary research in any area of the humanities, behavioral and social sciences, natural sciences, medicine, or engineering that involves data collection and/or processing by members of the public.

Health Disparities. Scientific Reports.

Deadline for Submission: July 10, 2023

The collection welcomes epidemiology studies, systematic reviews, interventional and clinical studies addressing topics of health disparities including studies on health disparities itself.

    Reporting Pediatric Translational Science Research. JAMA Pediatrics.

    Deadline for Submissions: open

    Call for manuscripts reporting original and innovative pediatric translational research with significant clinical relevance, with the goal of broadening the exposure of JAMA Pediatrics readers to cutting edge clinically relevant mechanistic translational research and broadening the potential audience for pediatric translational investigators to allow dissemination of their important research to an extensive clinically focused pediatric readership.

    The Practice of Inclusion Science: Reimagining and Retooling Approaches to Diversity, Health Equity, and Inclusion. Alzheimer’s & Dementia: Translational Research & Clinical Interventions.

    Deadline for Submissions: open

    In response to the need to stimulate broader discussion regarding AD/ADRD health disparities and practices that advance scientific inclusion in translational and clinical AD/ADRD research, we are soliciting papers that critically evaluate specific approaches to advancing investigation of AD/ADRD health disparities, outline systematic efforts to promote scientific inclusion in translational and clinical AD/ADRD research, and address emergent methodological challenges that are critical to moving therapies effectively from clinical trials into health care delivery settings.